Adrenergic alpha-Agonists - Research News and Information

Wednesday, January 07, 2009

[Clonidine in the treatment of cancer pain]

Nov 2008 Clonidine is an alpha2-adrenergic agonist with analgetic properties. Due to its side-effects, the drug is administered via the epidural or spinal route. A literature search yielded nine controlled studies on clonidine as a supplemental drug in the ... Read more...

Induced hypotension in orthognathic surgery: a comparative study of 2 pharmacological protocols.

30 Oct 2008 PURPOSE: The objective of this comparative study was to report on the use of 2 different pharmaceutical protocols involving 2 different anesthetic techniques (IV and balanced) to induce hypotension in patients submitted to orthognathic surgery by ... Read more...

Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study.

29 Sep 2008 Insulin resistance and sympathetic activity are related by a positive feedback system. However, which precedes the other still remains unclear. The present study aimed to investigate the predictive role of sympathoadrenal activity in the ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Adrenergic alpha-Agonists'

These are the very latest articles for this heading:

• [Clonidine in the treatment of cancer pain] Nov 2008
• Induced hypotension in orthognathic surgery: a comparative study of 2 pharmacological protocols. 30 Oct 2008
• Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. 29 Sep 2008
• The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. 29 Sep 2008
• Dexmedetomidine weakens dynamic cerebral autoregulation as assessed by transfer function analysis and the thigh cuff method. 29 Sep 2008
• Effects of clonidine on lidocaine-induced inhibition of axonal transport in cultured mouse dorsal root ganglion neurones. 10 Sep 2008
• Characterization of the inhibitory effect of vascular endothelium on agonist-induced vasoconstriction in rat mesenteric resistance arteries. 9 Sep 2008
• Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. 30 Aug 2008
• Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery. 30 Aug 2008
• Electrocardiographic parameters of captive lions (Panthera leo) and tigers (Panthera tigris) immobilized with ketamine plus xylazine. 30 Aug 2008
• Role of the multidomain protein spinophilin in blood pressure and cardiac function regulation. 16 Aug 2008
• Immobilising free-ranging Alpine chamois with xylazine, reversed with atipamezole. 7 Aug 2008
• Adrenergic regulation of cAMP/protein kinase A pathway in corneal epithelium and endothelium. 5 Aug 2008
• Alpha-1 adrenergic receptor transactivates signal transducer and activator of transcription-3 (Stat3) through activation of Src and epidermal growth factor receptor (EGFR) in hepatocytes. 30 Jul 2008
• Guanfacine in children with autism and/or intellectual disabilities. 30 Jul 2008
• Intranasal clonidine as a premedicant: three cases with unique indications. 30 Jul 2008
• Intravenous dexmedetomidine decreases lung permeability induced by intracranial hypertension in rats. 30 Jul 2008
• Intrathecal clonidine suppresses phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit in spinal dorsal horn neurons of rats with neuropathic pain. 30 Jul 2008
• Differences in hepatic cytochrome P450 activity correlate with the strain-specific biotransformation of medetomidine in AX/JU and IIIVO/JU inbred rabbits. 30 Jul 2008
• Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome. 30 Jul 2008

See a longer list of these articles.

Technical information about 'Adrenergic alpha-Agonists'

Definition: Drugs that selectively bind to and activate alpha adrenergic receptors.

Registry Number: 0

Descriptor UI: D000316

Alternative terms: Adrenergic alpha-Agonists; Adrenergic alpha Agonists; alpha-Agonists, Adrenergic; Receptor Agonists, Adrenergic alpha; Receptor Agonists, alpha-Adrenergic; Agonists, alpha-Adrenergic Receptor; Receptor Agonists, alpha Adrenergic; alpha-Adrenergic Receptor Agonist; Agonist, alpha-Adrenergic Receptor; Receptor Agonist, alpha-Adrenergic; alpha Adrenergic Receptor Agonist; alpha-Adrenergic Receptor Agonists; alpha Adrenergic Receptor Agonists; Adrenergic alpha-Agonist; Adrenergic alpha Agonist; alpha-Agonist, Adrenergic; alpha-Adrenergic Agonist; Agonist, alpha-Adrenergic; alpha Adrenergic Agonist; alpha-Adrenergic Agonists; Agonists, alpha-Adrenergic; alpha Adrenergic Agonists; Adrenergic alpha-Receptor Agonist; Adrenergic alpha Receptor Agonist; Agonist, Adrenergic alpha-Receptor; alpha-Receptor Agonist, Adrenergic; Adrenergic alpha-Receptor Agonists; Adrenergic alpha Receptor Agonists; Agonists, Adrenergic alpha-Receptor; alpha-Receptor Agonists, Adrenergic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.050.100.100; D27.505.696.577.050.100.100;

Online Note: use ADRENERGIC ALPHA-AGONISTS to search ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (as Prov 1969-72)

History Note: 95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (Prov 1969-72)

Technical Notes: GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-ANTAGONISTS; DF: ADREN ALPHA AGON or ADREN ALPHA AG